CoChat

Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu

Open access
Pickart, Loren, Margolina, Anna · 2021 · OBM Genetics

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; 10 of the 47 sources its claims cite were checked for support.

Abstract

The human copper-binding peptide GHK-Cu is a naturally occurring small plasma tripeptide (glycyl-l-histidyl-l-lysine) with a high affinity for copper (2+). GHK-Cu has multiple biological effects. It is known to stimulate regeneration of skin, nervous tissue, bones, lungs and liver, protect liver from oxidative damage, restore activity of irradiated fibroblasts, reduce inflammation and increase levels of antioxidant enzymes. Recent studies established that GHK modulates activity of a number of genes. It has been shown to reverse pathological expression of 70% genes in a gene signature for metastasis-prone colon cancer and shift gene expression in COPD lungs from destruction to healthy remodeling. In this paper, we present GHK-Cu’s gene effects on MCF7 breast cancer cells and PC3 prostate cancer cells and review laboratory evidence supporting GHK’s ability to restore tissue integrity and health via multiple mechanisms, which can be beneficial for cancer treatment.

Overview

CoChat Summary

## TL;DR

The paper uses gene-profiling data from the Broad Institute Connectivity Map to examine how the human copper-binding peptide GHK-Cu affects gene expression in MCF7 breast cancer cells and PC3 prostate cancer cells. It reports that GHK upregulates several apoptosis and tumor-suppressor genes and downregulates genes associated with cancer progression and drug resistance, and argues this supports further study of GHK-Cu in cancer therapy.

## Key findings

  • GHK upregulated caspase genes involved in apoptosis, including CASP1 (272% in MCF7; 173% in PC3), CASP3 (19%; 79%), CASP6 (62%; 21%), CASP7 (93%; 10%), CASP8 (NS; 501%), and CASP10 (1781%; 195%).
  • The paper reports strong upregulation of several tumor-suppressor/growth-inhibitory genes, including USP29 (1749% in MCF7; 687% in PC3), IFNA21 (5336%; 507%), TP73 (1634%; 283%), LEFTY2 (1961%; 620%), and IL25 (690%; 1040%).
  • ATM is highlighted as especially important, and the paper states that GHK stimulates ATM RNA production by 80% in breast cancer cells and 120% in prostate cells.
  • GHK downregulated genes associated with cancer progression/drug resistance, including ABCB1 (-900% in MCF7; -2451% in PC3), STAT5A (-4077%; -359%), IGF1 (NS; -864%), FGFR2 (-243%; -235%), FAIM2 (-590%; -462%), and TNF (124%; -153%).

## Methods

  • The study used two approaches to assess GHK effects on gene expression: Gene Ontology-based analysis and a manual search of all genes affected by GHK.
  • It analyzed public data from the Broad Institute Connectivity Map (CMap), using GHK profiles from PC3 human prostate cancer cells and MCF7 human breast cancer cells.
  • Data were processed in GenePattern; CEL files were handled with MAS5 and background correction, then viewed in ComparativeMarkerSelectionViewer and reported as fold-changes converted into percentage changes. The paper also compared GHK to other compounds using the Broad Institute Chembank.

## Limitations

  • The authors state that the Gene Ontology approach is limited because it does not cover all human cancers; they note there are over 100 human cancers and not all are represented.
  • The paper itself says that gene data alone would not be enough to conclude GHK should become an anti-cancer therapeutic, so the interpretation is suggestive rather than definitive.
  • Evident from the text: this is a computational / database-based analysis of cell-line profiles, so it does not report direct experiments measuring cancer outcomes in patients.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.21926/obm.genet.2102128

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

10 Valid · 3 Not valid · 31 Not checked · 35 Own results and interpretations

22 more claims

Create a free account to see all 79 claims and to verify the 6 references still open.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 37
  • Borderline: one of the tests for a substantial claim is unclear. 1
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Citations

Cites

Show all 46 references

Research works printed but not linked: 3

  1. Pickart L, Margolina A. Anti-aging activity of the GHK peptide-the skin and beyond. J Aging Res Clin Pract. 2012; 1: 13-15.
  2. Cherdakov VY, Smakhtin MY, Dubrovin GM, Dudka VT, Bobyntsev II. Synergetic antioxidant and reparative action of thymogen, dalargin and peptide gly-his-lys in tubular bone fractures. Exp Biol Med. 2010; 4: 15-20.
  3. Sakuma S, Ishimura M, Yuba Y, Itoh Y, Fujimoto Y. The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. Int J Physiol Pathophysiol Pharmacol. 2018; 10: 132.

Cited by

See all 3

Metadata

Authors
Pickart, L., & Margolina, A.
Corresponding author
Margolina, Anna
Venue
OBM Genetics
Published
2021-04-06
Volume
05
Issue
02
Pages
1-18
ISSN
2577-5790 (ISSN-L)
OpenAlex
W3151687174
Cited by
3
References
41
Citations by year
2026: 1 · 2023: 2
FWCI
0.32
Type
journal article
Language
en
Open access
Locations
OBM Genetics (publishedVersion, cc-by)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
Keywords
GHK-Cu, copper-binding peptides, gene expression modulation, MCF-7 cells, PC-3 cells, breast cancer, prostate cancer, copper, anticancer peptides, tissue regeneration, oxidative stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu. https://app.cochat.ai/papers/10.21926/obm.genet.2102128
The paper
Pickart, L., & Margolina, A. (2021). Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu. OBM Genetics. https://doi.org/10.21926/obm.genet.2102128

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.